Answers are grounded in this paper and cite their sources.
Observational study investigates the link between CHIP mutations and rheumatoid arthritis risk in a UK cohort, suggesting no significant associations.
Common CHIP mutations, including TET2, TP53, and SF3B1 mutations, were not associated with risk of incident RA when restricted to those with most complete general outpatient and hospital record follow-up in the UK Biobank.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: